Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke

被引:0
作者
E M Messier
K Bahmed
R M Tuder
H W Chu
R P Bowler
B Kosmider
机构
[1] National Jewish Health,Department of Medicine
[2] University of Colorado School of Medicine,undefined
来源
Cell Death & Disease | 2013年 / 4卷
关键词
alveolar type II cells; cigarette smoke; trolox; Nrf2; lung;
D O I
暂无
中图分类号
学科分类号
摘要
Cigarette smoke (CS) is a main risk factor for chronic obstructive pulmonary disease (COPD). Oxidative stress induced by CS causes DNA and lung damage. Oxidant/antioxidant imbalance occurs in the distal air spaces of smokers and in patients with COPD. We studied the effect of oxidative stress generated by CS both in vivo and in vitro on murine primary alveolar type II (ATII) cells isolated from nuclear erythroid 2-related factor-2 (Nrf2)−/− mice. We determined human primary ATII cell injury by CS in vitro and analyzed ATII cells isolated from smoker and non-smoker lung donors ex vivo. We also studied whether trolox (water-soluble derivative of vitamin E) could protect murine and human ATII cells against CS-induced DNA damage and/or decrease injury. We analyzed oxidative stress by 4-hydroxynonenal expression, reactive oxygen species (ROS) generation by Amplex Red Hydrogen Peroxide Assay, Nrf2, heme oxygenase 1, p53 and P53-binding protein 1 (53BP1) expression by immonoblotting, Nrf2 nuclear translocation, Nrf2 and p53 DNA-binding activities, apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay and cytokine production by ELISA. We found that ATII cells isolated from Nrf2−/− mice are more susceptible to CS-induced oxidative DNA damage mediated by p53/53BP1 both in vivo and in vitro compared with wild-type mice. Therefore, Nrf2 activation is a key factor to protect ATII cells against injury by CS. Moreover, trolox abolished human ATII cell injury and decreased DNA damage induced by CS in vitro. Furthermore, we found higher inflammation and p53 mRNA expression by RT-PCR in ATII cells isolated from smoker lung donors in comparison with non-smokers ex vivo. Our results indicate that the Nrf2 and p53 cross talk in ATII cells affect the susceptibility of these cells to injury by CS. Trolox can protect against oxidative stress, genotoxicity and inflammation induced by CS through ROS scavenging mechanism, and serve as a potential antioxidant prevention strategy against oxidative injury of ATII cells in CS-related lung diseases.
引用
收藏
页码:e573 / e573
相关论文
共 266 条
  • [1] Barnes PJ(2004)Mediators of chronic obstructive pulmonary disease Pharmacol Rev 56 515-548
  • [2] Marin L(2011)Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management Expert Opin Drug Deliv 8 1205-1220
  • [3] Colombo P(2007)Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis Am J Physiol Lung Cell Mol Physiol 292 L1211-L1218
  • [4] Bebawy M(2003)p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice Mol Cell Biol 23 2556-2563
  • [5] Young PM(2011)53BP1-mediated DNA double strand break repair: insert bad pun here DNA Repair (Amst) 10 1071-1076
  • [6] Traini D(2010)Expression of 53BP1 as a cisplatin-resistant marker in patients with lung adenocarcinomas Oncol Rep 24 321-328
  • [7] van der Toorn M(2006)Nrf2 defends the lung from oxidative stress Antioxid Redox Signal 8 76-87
  • [8] Slebos DJ(2001)Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes Mol Med 7 135-145
  • [9] de Bruin HG(2010) by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione Toxicol Appl Pharmacol 244 43-56
  • [10] Leuvenink HG(2010)Nrf2 protects against airway disorders Expert Opin Ther Targets 14 329-346